U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 4

2.
Figure 4

Figure 4. From: Potential Role of UGT Pharmacogenetics in Cancer Treatment and Prevention: Focus on Tamoxifen.

Analysis of glucuronidation activities against trans-4-OH-TAM and trans-endoxifen in HLM stratified by UGT2B7 genotypes. Glucuronidation assays were performed and 4-OH-TAM and endoxifen glucuronides separated by UPLC as described previously. (A) trans-4-OH-TAM and UGT2B7 codon 268 genotypes; (B) trans-endoxifen and UGT2B7 codon 268 genotypes. Comparative analysis was performed using the wild-type UGT2B7268His as the referent; *P < 0.001; **P < 0.002, and error bars represent standard error.

Philip Lazarus, et al. Ann N Y Acad Sci. ;1155:99-111.
3.
Figure 3

Figure 3. From: Potential Role of UGT Pharmacogenetics in Cancer Treatment and Prevention: Focus on Tamoxifen.

Competitive binding assay of TAM and metabolites of TAM. The cytosolic fraction of MCF-7 cells was incubated (500 μL total reaction) for 18 h at 4°C with the indicated concentration of competitor (10−9 to 10−6 M) or [3H]-labeled E2 (10−11 to 10−6 M). After incubation, 5% dextran-coated charcoal was added to adsorb unbound ligand for 15 min at 4°C, and radioactivity was measured in the supernatant. Data are expressed as the percentage of specific binding of [3H]-E2 for the ER when competitor was not present. Numbers in parentheses, RBA to ER for each test compound, with all data normalized to the RBA of E2 (set at 100). (A) T4, trans-4-OH-TAM; T4O, trans-TAM-4-O-glucuronide, T4N, trans-4-OH-TAM-N-glucuronide; (B) C4, cis-4-OH-TAM; C4O, cis-TAM-4-O-glucuronide; C4N, cis-4-OH-TAM-N-glucuronide; (C) TE, trans-endoxifen; TEO, trans-endoxifen-O- glucuronide; CE, cis-endoxifen; CEO, cis-endoxifen-O-glucuronide; (D) TN, TAM-N-glucuronide.

Philip Lazarus, et al. Ann N Y Acad Sci. ;1155:99-111.
4.
Figure 2

Figure 2. From: Potential Role of UGT Pharmacogenetics in Cancer Treatment and Prevention: Focus on Tamoxifen.

Effect of TAM and TAM metabolites on PGR gene expression in MCF-7 cells. Cells were incubated with 1 × 10−10 M E2 for 12 h at 37°C in 5% CO2. Total RNA was extracted and PGR mRNA levels were determined by RT-PCR as described in the Methods section. PGR mRNA levels were expressed as the fold-induction of PGR mRNA levels observed for untreated cells (media). (A) PGR gene expression in E2-induced MCF-7 cells treated with TAM and 4-OH-TAM isomers or glucuronides; (B) PGR gene expression in E2-induced MCF-7 cells treated with endoxifen isomers or glucuronides. The E2 positive control, the media alone, and vehicle negative control are shown on both panels. E2, cells incubated with 1 × 10−10 M E2; vehicle, cells incubated with 0.1% DMSO; trans-4-OH, cells incubated with trans-4-OH- TAM; cis-4-OH, cells incubated with cis-4-OH-TAM, trans-4-OH-O, cells incubated with trans-TAM-4-O-glucuronide; cis-4-OH-O, cells incubated with cis-TAM-4-O-glucuronide; trans-4-OH-N, cells incubated with trans-4-OH-TAM-N+-glucuronide; cis-4-OH-N, cells incubated with cis-4-OH-TAM-N+-glucuronide; trans-E, cells incubated with trans-endoxifen; cis-E, cells incubated with cis-endoxifen; trans-E-O, cells incubated with trans-endoxifen-O-glucuronide; cis-E-O, cells incubated with cis-endoxifen-O-glucuronide; TAM, cells incubated with TAM; TAM-N, cells incubated with TAM-N-glucuronide. The figure legend describes the concentration of TAM or TAM metabolite used in this experiment. The mean ± standard error is shown for three experiments.

Philip Lazarus, et al. Ann N Y Acad Sci. ;1155:99-111.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center